Search research articles
Contact Us
Filters
Showing results (371-380 of 570) with videos related to
Page
of 57
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
March 20, 2009
mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning
Jennifer E Ayala, Yelin Chen, Jessica L Banko, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 23, 2008
Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties
Thomas M Bridges, Ashley E Brady, J Phillip Kennedy, et al.
Cellular Signalling
|
September 18, 2013
Reversible inhibitors of regulators of G-protein signaling identified in a high-throughput cell-based calcium signaling assay
Andrew J Storaska, Jian P Mei, Meng Wu, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 18, 2018
Discovery of 4-alkoxy-6-methylpicolinamide negative allosteric modulators of metabotropic glutamate receptor subtype 5
Andrew S Felts, Katrina A Bollinger, Christopher J Brassard, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 4, 2013
N-Acyl-N'-arylpiperazines as negative allosteric modulators of mGlu1: identification of VU0469650, a potent and selective tool compound with CNS exposure in rats
Kimberly M Lovell, Andrew S Felts, Alice L Rodriguez, et al.
Neurochemistry International
|
October 5, 2013
Neuronal ablation of p-Akt at Ser473 leads to altered 5-HT1A/2A receptor function
Christine Saunders, Michael Siuta, Sabrina D Robertson, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 16, 2022
Discovery of a potent M<sub>5</sub> antagonist with improved clearance profile. Part 1: Piperidine amide-based antagonists
Rory A Capstick, David Whomble, Douglas L Orsi, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 14, 2016
Further optimization of the M1 PAM VU0453595: Discovery of novel heterobicyclic core motifs with improved CNS penetration
Joseph D Panarese, Hykeyung P Cho, Jeffrey J Adams, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 29, 2016
Discovery and characterization of a novel series of N-phenylsulfonyl-1H-pyrrole picolinamides as positive allosteric modulators of the metabotropic glutamate receptor 4 (mGlu4)
Rocco D Gogliotti, Anna L Blobaum, Ryan M Morrison, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 22, 2017
Discovery and optimization of 3-(4-aryl/heteroarylsulfonyl)piperazin-1-yl)-6-(piperidin-1-yl)pyridazines as novel, CNS penetrant pan-muscarinic antagonists
Aaron M Bender, Rebecca L Weiner, Vincent B Luscombe, et al.
Page
of 57
Search research articles
Search
Showing results (371-380 of 570) with videos related to
Sort By:
Page
of 57
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
March 20, 2009
mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning
Jennifer E Ayala, Yelin Chen, Jessica L Banko, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 23, 2008
Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties
Thomas M Bridges, Ashley E Brady, J Phillip Kennedy, et al.
Cellular Signalling
|
September 18, 2013
Reversible inhibitors of regulators of G-protein signaling identified in a high-throughput cell-based calcium signaling assay
Andrew J Storaska, Jian P Mei, Meng Wu, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 18, 2018
Discovery of 4-alkoxy-6-methylpicolinamide negative allosteric modulators of metabotropic glutamate receptor subtype 5
Andrew S Felts, Katrina A Bollinger, Christopher J Brassard, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 4, 2013
N-Acyl-N'-arylpiperazines as negative allosteric modulators of mGlu1: identification of VU0469650, a potent and selective tool compound with CNS exposure in rats
Kimberly M Lovell, Andrew S Felts, Alice L Rodriguez, et al.
Neurochemistry International
|
October 5, 2013
Neuronal ablation of p-Akt at Ser473 leads to altered 5-HT1A/2A receptor function
Christine Saunders, Michael Siuta, Sabrina D Robertson, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 16, 2022
Discovery of a potent M<sub>5</sub> antagonist with improved clearance profile. Part 1: Piperidine amide-based antagonists
Rory A Capstick, David Whomble, Douglas L Orsi, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 14, 2016
Further optimization of the M1 PAM VU0453595: Discovery of novel heterobicyclic core motifs with improved CNS penetration
Joseph D Panarese, Hykeyung P Cho, Jeffrey J Adams, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 29, 2016
Discovery and characterization of a novel series of N-phenylsulfonyl-1H-pyrrole picolinamides as positive allosteric modulators of the metabotropic glutamate receptor 4 (mGlu4)
Rocco D Gogliotti, Anna L Blobaum, Ryan M Morrison, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 22, 2017
Discovery and optimization of 3-(4-aryl/heteroarylsulfonyl)piperazin-1-yl)-6-(piperidin-1-yl)pyridazines as novel, CNS penetrant pan-muscarinic antagonists
Aaron M Bender, Rebecca L Weiner, Vincent B Luscombe, et al.
Page
of 57